美股期权个股详情

EYPT250117P10000

添加自选

1.40
-0.62-30.69%

延时15分钟行情收盘价 01/07 16:00 (美东)

1.40最高价1.40最低价

EyePoint Pharmaceuticals资讯中心

新闻

公告

评级

eyepoint pharmaceuticals 分析师评级
Benzinga03:48
花旗首予EyePoint Pharmaceuticals(EYPT.US)买入评级，目标价33美元
富途资讯01/07 19:31
JonesTrading维持EyePoint Pharmaceuticals(EYPT.US)买入评级，维持目标价45美元
富途资讯01/03 00:32
H.C. Wainwright维持EyePoint Pharmaceuticals(EYPT.US)买入评级，维持目标价22美元
富途资讯2024/12/06 01:31
JonesTrading维持EyePoint Pharmaceuticals(EYPT.US)买入评级，维持目标价45美元
富途资讯2024/12/06 00:33
eyepoint pharmaceuticals价格目标保持在$22.00/Share，由HC Wainwright & Co。
道琼斯2024/12/05 19:30
eyepoint pharmaceuticals 分析师评级
Benzinga2024/12/05 19:21
JonesTrading维持EyePoint Pharmaceuticals(EYPT.US)买入评级，维持目标价45美元
富途资讯2024/12/03 06:31
贝雅维持EyePoint Pharmaceuticals(EYPT.US)买入评级，下调目标价至33美元
富途资讯2024/11/11 20:31
JonesTrading维持EyePoint Pharmaceuticals(EYPT.US)买入评级，维持目标价45美元
富途资讯2024/11/11 20:31
H.C. Wainwright维持EyePoint Pharmaceuticals(EYPT.US)买入评级，下调目标价至22美元
富途资讯2024/11/11 20:31
eyepoint pharmaceuticals被HC Wainwright & Co.维持为买入
道琼斯2024/11/11 20:24
eyepoint pharmaceuticals股价目标由HC Wainwright & Co.下调至22.00美元/股，原先为30.00美元。
道琼斯2024/11/11 20:24
Chardan Capital维持对eyepoint pharmaceuticals的买入评级，并将目标股价上调至33美元
Benzinga2024/11/09 06:16
TD Cowen维持EyePoint Pharmaceuticals(EYPT.US)买入评级，下调目标价至20美元
富途资讯2024/11/08 01:30
eyepoint pharmaceuticals：临床试验进展及有望的中期数据推动了买入评级
TipRanks2024/11/08 00:50
丰业银行维持EyePoint Pharmaceuticals(EYPT.US)买入评级，维持目标价18美元
富途资讯2024/10/29 19:34
eyepoint pharmaceuticals被查丹资本维持买入评级
道琼斯2024/10/29 19:11
eyepoint pharmaceuticals 分析师评级
Benzinga2024/10/29 19:00
第一资本维持EyePoint Pharmaceuticals(EYPT.US)买入评级，维持目标价35美元
富途资讯2024/10/28 23:32